Radiation Oncology/RTOG Trials/8519

From Wikibooks, open books for an open world
< Radiation Oncology‎ | RTOG Trials
Jump to navigation Jump to search


RTOG 85-19 (PROSTATE)

  • Title: Phase II (title not available)
  • Objectives: (not available)
  • Protocol: (not available)
  • Eligibility: Bulky primary lesions, stage B2 and C, with disease confined to the pelvis
  • Enrolled: 31 patients
  • Conclusion:
    • PMID 2146872 -- Phase II Radiation Therapy Oncology Group study of hormonal cytoreduction with flutamide and Zoladex in locally advanced carcinoma of the prostate treated with definitive radiotherapy. (Pilepich MV, Am J Clin Oncol 1990). Conclusion: The observed toxicity appears acceptable and the response rate encouraging.